PAA 4.26% 22.5¢ pharmaust limited

Ann: PharmAust to present at Emerging ASX Gems Conference, page-47

  1. 270 Posts.
    lightbulb Created with Sketch. 355
    Thanks Pete.

    Upon reading the article it seems to me that we could equally qualify for Orphan Drug Designation as well as Breakthrough Therapy.

    I'd like to know if there is a reason not to pursue both avenues.

    If we achieve FDA approval for Breakthrough Therapy then surely an interested party would be eager to advance a proposal to PAA


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.010(4.26%)
Mkt cap ! $89.08M
Open High Low Value Volume
23.5¢ 23.5¢ 22.0¢ $170.5K 749.0K

Buyers (Bids)

No. Vol. Price($)
2 34313 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 24444 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
22.5¢
  Change
-0.010 ( 6.25 %)
Open High Low Volume
23.0¢ 23.0¢ 22.0¢ 246904
Last updated 15.57pm 14/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.